FSNS has been approved by the USDA-AMS Laboratory Approval Program for Export of Meat and Poultry Products for the analysis of the Beta-Agonist Ractopamine in Animal Muscle and Liver Tissues.
An increasing world population, with estimates of more than 9 billion people by 2050, and a decreasing cattle supply necessitates the use of feed technologies to meet the current and future demand of beef.